GETTING TECHNOLOGY AND THE TECHNOLOGY ENVIRONMENT RIGHT: LESSONS FROM MAIZE DEVELOPMENT IN SOUTHERN AFRICA

This paper examines two questions: (1) what were the most important factors that led to differential rates of adoption of maize technology by farmers in Zimbabwe, Zambia, and Malawi from 1910 to 1995? and (2) what do these experiences suggest about strategic investments in institutions and organizations needed to create a sustainable environment for technology development and adoption in the future? The analysis suggests that productivity increases are facilitated by (a) technology innovations throughout the agricultural system, (b) integration of technological innovations with changes in policies, organizations, human capital and infrastructure related to extension, input and output markets and processing services, and (c) coordination of these innovations across different stages of the agricultural system.Crop Production/Industries, Research and Development/Tech Change/Emerging Technologies,

Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials.

BACKGROUND: Parkinson\u27s disease (PD) patients using levodopa commonly develop dyskinesia and OFF episodes that reduce quality of life. OBJECTIVE: Evaluate prevalence of troublesome dyskinesia and OFF through the day, assessed by 30-minute intervals, as well as the mean number and duration of troublesome dyskinesia and OFF episodes, transitions between PD states, and effects of Gocovri® (amantadine) extended release capsules on these episodes. METHODS: Evaluate diary data from pooled Gocovri phase 3, placebo-controlled trials-analyzed for 17 hours following wake-up-at baseline and week 12. RESULTS: Diaries were evaluable for 162 patients. At baseline, 67% of patients woke up OFF, with prevalence decreasing to 13% at 2 hours and then remaining relatively steady at ∼12% (range, 6-17%) across half-hour intervals thereafter. Troublesome dyskinesia prevalence rose steadily from 5% to 24% over the first 2 hours, then fluctuated between 20% and 44% through the rest of the waking day. At baseline, patients experienced a mean of 3.0 daily episodes of troublesome dyskinesia (average duration 2.0 hours each), and 2.2 daily episodes of OFF (average duration 1.1 hour each). At week 12, Gocovri-treated patients showed greater reductions than placebo in troublesome dyskinesia and OFF episodes per day (treatment difference: -1.0 episodes and -0.4 episodes, respectively) and average episode duration (treatment difference: -0.6 hours and -0.3 hours, respectively). Mean duration of individual episodes of ON without troublesome dyskinesia (Good ON) increased by 5.0 hours for Gocovri, compared with 2.0 hours for placebo. Patients taking Gocovri experienced 2.2 fewer transitions between states than patients taking placebo. CONCLUSIONS: Troublesome dyskinesia and OFF occurred in the morning and throughout the waking day. Gocovri-treated patients experienced fewer, shorter episodes of both troublesome dyskinesia and OFF, thereby increasing the duration of continuous Good ON episodes and reducing the frequency of transitions between motor states

Invisible sunspots and rate of solar magnetic flux emergence

Aims. We study the visibility of sunspots and its influence on observed values of sunspot region parameters. Methods. We use Virtual Observatory tools provided by AstroGrid to analyse a sample of 6862 sunspot regions. By studying the distributions of locations where sunspots were first and last observed on the solar disk, we derive the visibility function of sunspots, the rate of magnetic flux emergence and the ratio between the durations of growth and decay phases of solar active regions. Results. We demonstrate that the visibility of small sunspots has a strong centre-to-limb variation, far larger than would be expected from geometrical (projection) effects. This results in a large number of young spots being invisible: 44% of new regions emerging in the west of the Sun go undetected. For sunspot regions that are detected, large differences exist between actual locations and times of flux emergence, and the apparent ones derived from sunspot data. The duration of the growth phase of solar regions has been, up to now, underestimated

A feasibility service evaluation of screening and treatment of group A streptococcal pharyngitis in community pharmacies

Objectives The UK 5 year antimicrobial resistance strategy recognizes the role of point-of-care diagnostics to identify where antimicrobials are required, as well as to assess the appropriateness of the diagnosis and treatment. A sore throat test-and-treat service was introduced in 35 community pharmacies across two localities in England during 2014–15. Methods Trained pharmacy staff assessed patients presenting with a sore throat using the Centor scoring system and patients meeting three or all four of the criteria were offered a throat swab test for Streptococcus pyogenes, Lancefield group A streptococci. Patients with a positive throat swab test were offered antibiotic treatment. Results Following screening by pharmacy staff, 149/367 (40.6%) patients were eligible for throat swab testing. Of these, only 36/149 (24.2%) were positive for group A streptococci. Antibiotics were supplied to 9.8% (n = 36/367) of all patients accessing the service. Just under half of patients that were not showing signs of a bacterial infection (60/123, 48.8%) would have gone to their general practitioner if the service had not been available. Conclusions This study has shown that it is feasible to deliver a community-pharmacy-based screening and treatment service using point-of-care testing. This type of service has the potential to support the antimicrobial resistance agenda by reducing unnecessary antibiotic use and inappropriate antibiotic consumption

Ultraluminous infrared galaxies: mergers of sub-L* galaxies?

A sample of 27 low-redshift, mostly cool, ultraluminous infrared galaxies (ULIRGs) has been imaged at 1.6 μm with the Hubble Space Telescope (HST) Near-Infrared Camera and Multi-Object Spectrometer (NICMOS). The majority (67%) of the sample's galaxies are multiple-nucleus galaxies with projected separations of up to 17 kpc, and the rest of the sample (33%) are single-nucleus galaxies, as determined by the NICMOS angular resolution limit. The average observed, integrated (host+nucleus) H magnitude of our HST H sample ULIRGs is -24.3, slightly above that of an L* galaxy (MH = -24.2), and 52% of the sample's galaxies have sub-L* luminosities. The ULIRGs in the HST H sample are not generated as a result of the merging of two luminous (i.e., ≥L*) spiral galaxies. Instead, the interactions and mergers occur in general between two, or in some cases more, less massive sub-L* (0.3-0.5L*) galaxies. Only one out of the 49 nuclei identified in the entire HST H sample has the properties of a bright quasar-like nucleus. On average, the brightest nuclei in the HST H sample galaxies (i.e., cool ULIRGs) are 1.2 mag fainter than warm ULIRGs and low-luminosity Bright Quasar Survey quasars (BQS QSOs) and 2.6 mag fainter than high-luminosity BQS QSOs. Since the progenitor galaxies involved in the merger are sub-L* galaxies, the mass of the central black hole in these ULIRGs would be only about (1-2) × 107 M☉, if the bulge-to-black hole mass ratio of nearby galaxies holds for ULIRGs. The estimated mass of the central black hole is similar to that of nearby Seyfert 2 galaxies but at least 1 order of magnitude lower than the massive black holes thought to be located at the center of high-luminosity QSOs. Massive nuclear starbursts with constant star formation rates of 10-40 M☉ yr-1 could contribute significantly to the nuclear H-band flux and are consistent with the observed nuclear H-band magnitudes of the ULIRGs in the HST H sample. An evolutionary merging scenario is proposed for the generation of the different types of ULIRGs and QSOs on the basis of the masses of the progenitors involved in the merging process. According to this scenario, cool ULIRGs would be the end product of the merging of two or more low-mass (0.3L*-0.5L*) disk galaxies. Warm ULIRGs and low-luminosity QSOs would be generated by a merger involving intermediate-mass (0.5 L*) disk galaxies. Under this scenario, warm ULIRGs could still be the dust-enshrouded phases of UV-bright low-luminosity QSOs, but cool ULIRGs, which are most ULIRGs, would not evolve into QSOs

Optical Imaging of Very Luminous Infrared Galaxy Systems: Photometric Properties and Late Evolution

A sample of 19 low redshift (0.03$<$z$<$0.07) very luminous infrared galaxy (VLIRG: $10^{11}L_\odot<$ L[8-1000 $\mu$m] $< 10^{12} L_\odot$) systems (30 galaxies) has been imaged in $B$, $V$, and $I$. These objects cover a luminosity range that is key to linking the most luminous infrared galaxies with the population of galaxies at large. We have obtained photometry for all of these VLIRG systems, the individual galaxies (when detached), and their nuclei, and the relative behavior of these classes has been studied in optical color-magnitude diagrams. The photometric properties of the sample are also compared with previously studied samples of ULIRGs. The mean observed photometric properties of VLIRG and ULIRG samples, considered as a whole, are indistinguishable at optical wavelengths. This suggests that not only ULIRG, but also the more numerous population of VLIRGs, have similar rest-frame optical photometric properties as the submillimeter galaxies (SMG), reinforcing the connection between low-{\it z} LIRGs -- high-{\it z} SMGs. When the nuclei of the {\it young} and {\it old} interacting systems are considered separately, some differences between the VLIRG and the ULIRG samples are found. In particular, the old VLIRGs are less luminous and redder than old ULIRG systems. If confirmed with larger samples, this behavior suggests that the late-stage evolution is different for VLIRGs and ULIRGs. Specifically, as suggested from spectroscopic data, the present photometric observations support the idea that the activity during the late phases of VLIRG evolution is dominated by starbursts, while a higher proportion of ULIRGs could evolve into a QSO type of object.Comment: 27 pages, 5 figures (degraded to reduce space). Figures 1 and 2 are multiple page figures (i.e. Fig 1a,b and Fig2a-g

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study

Purpose In this multicenter study, we evaluated the cumulative burden of morbidity (CBM) among > 1,200 testicular cancer survivors and applied factor analysis to determine the co-occurrence of adverse health outcomes (AHOs). Patients and Methods Participants were ≤ 55 years of age at diagnosis, finished first-line chemotherapy ≥ 1 year previously, completed a comprehensive questionnaire, and underwent physical examination. Treatment data were abstracted from medical records. A CBM score encompassed the number and severity of AHOs, with ordinal logistic regression used to assess associations with exposures. Nonlinear factor analysis and the nonparametric dimensionality evaluation to enumerate contributing traits procedure determined which AHOs co-occurred. Results Among 1,214 participants, approximately 20% had a high (15%) or very high/severe (4.1%) CBM score, whereas approximately 80% scored medium (30%) or low/very low (47%). Increased risks of higher scores were associated with four cycles of either ifosfamide, etoposide, and cisplatin (odds ratio [OR], 1.96; 95% CI, 1.04 to 3.71) or bleomycin, etoposide, and cisplatin (OR, 1.44; 95% CI, 1.04 to 1.98), older attained age (OR, 1.18; 95% CI, 1.10 to 1.26), current disability leave (OR, 3.53; 95% CI, 1.57 to 7.95), less than a college education (OR, 1.44; 95% CI, 1.11 to 1.87), and current or former smoking (OR, 1.28; 95% CI, 1.02 to 1.63). CBM score did not differ after either chemotherapy regimen ( P = .36). Asian race (OR, 0.41; 95% CI, 0.23 to 0.72) and vigorous exercise (OR, 0.68; 95% CI, 0.52 to 0.89) were protective. Variable clustering analyses identified six significant AHO clusters (χ2 P < .001): hearing loss/damage, tinnitus (OR, 16.3); hyperlipidemia, hypertension, diabetes (OR, 9.8); neuropathy, pain, Raynaud phenomenon (OR, 5.5); cardiovascular and related conditions (OR, 5.0); thyroid disease, erectile dysfunction (OR, 4.2); and depression/anxiety, hypogonadism (OR, 2.8). Conclusion Factors associated with higher CBM may identify testicular cancer survivors in need of closer monitoring. If confirmed, identified AHO clusters could guide the development of survivorship care strategies